Cyclooxygenase-independent effects of aspirin on HT-29 human colon cancer cells, revealed by oligonucleotide microarrays

Biotechnology Letters

Volumn 28, Issue 16, 2006, Pages 1263-1270

  Yin, Hongying ^a,b   Xu, Hao ^c   Zhao, Yongchao ^a,b   Yang, Weiping ^c   Cheng, Jing ^a,b   Zhou, Yuxiang ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

^c CapitalBio Corporation   (China)

Author keywords

Apoptosis; Aspirin; Colon cancer; Cyclooxygenase 2 (COX 2); DNA microarray

Indexed keywords

APOPTOSIS; ASPIRIN; COLON CANCER; DNA MICROARRAY;

DNA; DRUG PRODUCTS; GENES; GENETIC ENGINEERING; MORPHOLOGY; NUCLEIC ACIDS; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

ENZYMES;

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

APOPTOSIS; ARTICLE; BIOTECHNOLOGY; CELL STRAIN HT29; CLUSTER ANALYSIS; COLON TUMOR; DNA MICROARRAY; ELECTRON MICROSCOPY; GENOME; HUMAN; METHODOLOGY; PHYLOGENY; TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; BIOTECHNOLOGY; CLUSTER ANALYSIS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; GENOME; HT29 CELLS; HUMANS; MICROSCOPY, ELECTRON; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLOGENY; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 33746053797     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-006-9084-9     Document Type: Article

References (37)

1. Amin AR, Vyas P, Attur M, Leszczynska-Piziak J, Patel IR, Weissmann G, Abramson SB (1995) The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 92:7926-7930
2. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891-899
3. Castano E, Dalmau M, Barragan M, Pueyo G, Bartrons R, Gil J (1999) Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells. Br J Cancer 81:294-299
4. Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS (2004) A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 140:157-166
5. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19-20
6. Fenwick SW, Toogood GJ, Lodge JP, Hull MA (2003) The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 125:716-729
7. Gagna CE, Winokur D, Clark Lambert W (2004) Cell biology, chemogenomics and chemoproteomics. Cell Biol Int 28:755-764
8. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121:241-246
9. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Coldtiz GA, Willett WC, Speizwer FE (1995) Aspirin and the risk of colorectal cancer in woman. N Engl J Med 333:609-614
10. Hardwick JC, Van Santen M, Van Den Brink GR, Van Deventer SJ, Peppelenbosch MP (2004) DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis 25:1293-1298
11. Henry D, Dobson A, Turner C, Hall P, Forbes C, Patey P (1991) NSAIDs and risk of upper gastrointestinal bleeding. Lancet 337:730
12. Hsi LC, Baek SJ, Eling TE (2000) Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells. Exp Cell Res 256:563-570
13. Lynch S, Brogden RN (1986) Etodolac. A preliminary review of its pharmacodynamic activity and therapeutic use. Drugs 31:288-300
14. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett Jr DE, Hartwell LH, Brown PO, Friend SH (1998) Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4:1293-1301
15. Marx J (2001) Cancer research. Anti-inflammatories inhibit cancer growth - but how? Science 291:581-582
16. Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B (1998) Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 55:53-64
17. Rahme E, Barkun AN, Toubouti Y, Bardou M (2003) The cyclooxygenase-2- selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence. Gastroenterology 125:404-412
18. Reddy BS, Rao CV, Rivenson A, Kelloff G (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14:1493-1497
19. Ricchi P, Pignata S, Di Popolo A, Memoli A, Apicella A, Zarrilli R, Acquaviva AM (1997) Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer 73:880-884
20. Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122:518-523
21. Ruschoff J, Wallinger S, Dietmaier W, Bocker T, Brockhoff G, Hofstadter F, Fishel R (1998) Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 95:11301-11306
22. Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T, Nakano H (2003) NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22:3898-3909
23. Schernhammer ES, Kang JH, Chan AT, Michaud DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS (2004) A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst 96:22-28
24. Smith ML, Hawcroft G, Hull MA (2000) The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36:664-674
25. Stark LA, Din FV, Zwacka RM, Dunlop MG (2001) Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 15:1273-1275
26. Subbegowda R, Frommel T (1998) Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest. Cancer Res 58:2772-2776
27. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath Jr CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322-1327
28. Totzke G, Schulze-Osthoff K, Janicke RU (2003) Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 22:8021-8030
29. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 87:1663-1667
30. Vanchieri C (2004) Vioxx withdrawal alarms cancer prevention researchers. J Natl Cancer Inst 96:1734-1735
31. Wang D, Mann JR, DuBois RN (2005) The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128:1445-1461
32. Watson AJ (2006) An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol 57:107-121
33. Yamomoto Y, Yin MJ, Lin KM, Gaynor RB (1999) Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 274:27307-27314
34. Yang YY, Hu CJ, Chang SM, Tai TY, Leu SJ (2004) Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells. Atherosclerosis 174:207-213
35. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77-80
36. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989-992
37. Zhang L, Zhang Y, Zhou Y, An S, Cheng J (2002) Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J Antimicrob Chemother 49:905-915